PRIOR AUTH-PRESCRIPTION DRUGS House SponsorsRep. Jenn Ladisch Douglass, Gregg Johnson, Kelly M. Cassidy, Margaret Croke, Mary Beth Canty and Lilian Jiménez 1/7/2025HouseSession Sine Die 215 ILCS 200/52 new Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; or for specified prescription drugs, including insulin, human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone. 2/7/2024HouseFiled with the Clerk by Rep. Jenn Ladisch Douglass 2/8/2024HouseFirst Reading 2/8/2024HouseReferred to Rules Committee 2/21/2024HouseAdded Co-Sponsor Rep. Gregg Johnson 2/21/2024HouseAdded Co-Sponsor Rep. Kelly M. Cassidy 2/26/2024HouseAdded Co-Sponsor Rep. Margaret Croke 2/26/2024HouseAdded Co-Sponsor Rep. Mary Beth Canty 3/5/2024HouseAssigned to Health Care Availability & Accessibility Committee 3/20/2024HouseHouse Committee Amendment No. 1 Filed with Clerk by Rep. Jenn Ladisch Douglass 3/20/2024HouseHouse Committee Amendment No. 1 Referred to Rules Committee 3/21/2024HouseHouse Committee Amendment No. 1 Rules Refers to Health Care Availability & Accessibility Committee 4/5/2024HouseRule 19(a) / Re-referred to Rules Committee 4/5/2024HouseHouse Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee 4/24/2024HouseAdded Co-Sponsor Rep. Lilian Jiménez 1/7/2025HouseSession Sine Die